B, P., AM, A., A, A., R, M., AM, K., M, M., . . . KS, O. (2024). Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A Secondary Analysis of the MORDOR Cluster-Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 79(5), 1136. https://doi.org/10.1093/cid/ciae267
Chicago Style (17th ed.) CitationB, Peterson, et al. "Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A Secondary Analysis of the MORDOR Cluster-Randomized Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 79, no. 5 (2024): 1136. https://doi.org/10.1093/cid/ciae267.
MLA (9th ed.) CitationB, Peterson, et al. "Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A Secondary Analysis of the MORDOR Cluster-Randomized Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 79, no. 5, 2024, p. 1136, https://doi.org/10.1093/cid/ciae267.